Réglementation des prix et formes de la concurrence dans l'industrie pharmaceutique

Price regulation and competition patterns in the ethical drug industry in france This article gives the results of an econometric modelization of the ethical drugs price and quantity determination institutionnal process for France. From price and promotion elasticities, it is shown that competition on the pharmaceutical market essentially occurs through promotion and product differenciation rather than through prices. A comparison with elasticities that has been measured in other institutionnal contexts, and the results of an analysis of the price dynamic of new chimical entities, drive to the conclusion that the mentioned competition patterns are in fact greatly determined by the price regulation process itself.